RSVpreF
RSVpreF is a biological therapy with 12 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
3
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.
A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF
A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults
Clinical Trials (12)
Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.
A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF
A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults
Study of HIV-Exposed Pregnancies and Transplacental Antibody Delivery Following RSVpreF
Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.
A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease
A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.
A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).
A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults
Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults
All 12 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 12